21
Participants
Start Date
April 30, 2008
Primary Completion Date
March 31, 2014
Study Completion Date
March 31, 2014
Neulasta (Pegylated)
Subjects will receive 6mg/dose given every 2 weeks for 12 weeks. Subjects less than 45kg will receive 100mcg/kg/dose every 2 weeks for 12 weeks.
Placebo
Placebo injections will be given in identical volumes in identical syringes in the identical subcutaneous manner. 6mg/dose given every 2 weeks for 12 weeks. Subjects less than 45kg will receive 100mcg/kg/dose every 2 weeks for 12 weeks.
Mixed Meal Tolerance Test (MMTT)
This is a 2 hour test to find out how much C-peptide is being produced. C-peptide is used to measure the insulin being made by the cells of the pancreas. Both groups will have this test performed.
Blood test
HbA1c is a blood test that measures the average blood sugar control and will be performed in both groups.
DNA Test
The HLA test looks at the different chromosomes (DNA) for diabetes and will be performed in both groups.
University of Florida, Gainesville
Collaborators (1)
Juvenile Diabetes Research Foundation
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of Florida
OTHER